317 related articles for article (PubMed ID: 11850964)
1. Levels of antibody to Staphylococcus epidermidis in patients with acne vulgaris.
Puhvel SM; Warnick MA; Sternberg TH
Arch Dermatol; 1965 Jul; 92(1):88-90. PubMed ID: 11850964
[TBL] [Abstract][Full Text] [Related]
2. IgG subclasses specific to Staphylococcus epidermidis and Propionibacterium acnes in patients with acne vulgaris.
Ashbee HR; Muir SR; Cunliffe WJ; Ingham E
Br J Dermatol; 1997 May; 136(5):730-3. PubMed ID: 9205507
[TBL] [Abstract][Full Text] [Related]
3. [Skin reactions to antigens of propionibacterium acnes in patients with acne vulgaris treated with autovaccine].
Załuga E
Ann Acad Med Stetin; 1998; 44():65-85. PubMed ID: 9857532
[TBL] [Abstract][Full Text] [Related]
4. Antibody response to crude cell lysate of propionibacterium acnes and induction of pro-inflammatory cytokines in patients with acne and normal healthy subjects.
Basal E; Jain A; Kaushal GP
J Microbiol; 2004 Jun; 42(2):117-25. PubMed ID: 15357305
[TBL] [Abstract][Full Text] [Related]
5. Different pro-inflammatory and immunogenic potentials of Propionibacterium acnes and Staphylococcus epidermidis: implications for chronic inflammatory acne.
Białecka A; Mak M; Biedroń R; Bobek M; Kasprowicz A; Marcinkiewicz J
Arch Immunol Ther Exp (Warsz); 2005; 53(1):79-85. PubMed ID: 15761379
[TBL] [Abstract][Full Text] [Related]
6. [The resistance of Propionibacterium acnes and Staphylococcus epidermidis to cyclines. The Research and Study Group on Acne].
Noyon V; Legallou F; Richet H; Dreno B
Ann Dermatol Venereol; 1998 Dec; 125(12):885-7. PubMed ID: 9922860
[TBL] [Abstract][Full Text] [Related]
7. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease.
Sugisaki H; Yamanaka K; Kakeda M; Kitagawa H; Tanaka K; Watanabe K; Gabazza EC; Kurokawa I; Mizutani H
J Dermatol Sci; 2009 Jul; 55(1):47-52. PubMed ID: 19375895
[TBL] [Abstract][Full Text] [Related]
8. Erythromycin-resistance of cutaneous bacterial flora in acne.
Dreno B; Reynaud A; Moyse D; Habert H; Richet H
Eur J Dermatol; 2001; 11(6):549-53. PubMed ID: 11701406
[TBL] [Abstract][Full Text] [Related]
9. STUDY OF ANTIBODY LEVELS TO CORYNEBACTERIUM ACNES. IN THE SERUM OF PATIENTS WITH ACNE VULGARIS, USING BACTERIAL AGGLUTINATION, AGAR GEL IMMUNODIFFUSION, AND IMMUNOFLUORESCENCE TECHNIQUES.
PUHVEL SM; BARFATANI M; WARNICK M; STERNBERG TH
Arch Dermatol; 1964 Oct; 90():421-7. PubMed ID: 14184490
[No Abstract] [Full Text] [Related]
10. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions.
Nishijima S; Kurokawa I; Katoh N; Watanabe K
J Dermatol; 2000 May; 27(5):318-23. PubMed ID: 10875198
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic resistance of microbial strains isolated from Korean acne patients.
Moon SH; Roh HS; Kim YH; Kim JE; Ko JY; Ro YS
J Dermatol; 2012 Oct; 39(10):833-7. PubMed ID: 22779738
[TBL] [Abstract][Full Text] [Related]
12. [The assessment of bacterial flora and antibiotic-sensitivity of bacteria isolated from conjunctival sac, skin of the eyelids and inflammatory lesions in patients with acne vulgaris and rosacea].
Kaszuba-Bartkowiak K; Goś R
Przegl Lek; 2007; 64(12):991-6. PubMed ID: 18595500
[TBL] [Abstract][Full Text] [Related]
13. The antibiotic susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne.
Nishijima S; Akamatsu H; Akamatsu M; Kurokawa I; Asada Y
J Dermatol; 1994 Mar; 21(3):166-71. PubMed ID: 8014270
[TBL] [Abstract][Full Text] [Related]
14. [Immunological response to bacterial antigens in acne vulgaris].
Hadam I; Batová D; Horácková P
Cesk Dermatol; 1972 Feb; 47(1):22-7. PubMed ID: 4258868
[No Abstract] [Full Text] [Related]
15. Susceptibility of Propionibacterium acnes and Staphylococcus epidermidis to killing by MPO-halide system products. Implication for taurine bromamine as a new candidate for topical therapy in treating acne vulgaris.
Marcinkiewicz J; Biedroń R; Białecka A; Kasprowicz A; Mak M; Targosz M
Arch Immunol Ther Exp (Warsz); 2006; 54(1):61-8. PubMed ID: 16642259
[TBL] [Abstract][Full Text] [Related]
16. Relationship between quinolone use and resistance of Staphylococcus epidermidis in patients with acne vulgaris.
Nakase K; Yoshida A; Saita H; Hayashi N; Nishijima S; Nakaminami H; Noguchi N
J Dermatol; 2019 Sep; 46(9):782-786. PubMed ID: 31254314
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the severity of acne vulgaris and antimicrobial resistance of bacteria isolated from acne lesions in a hospital in Japan.
Nakase K; Nakaminami H; Takenaka Y; Hayashi N; Kawashima M; Noguchi N
J Med Microbiol; 2014 May; 63(Pt 5):721-728. PubMed ID: 24523159
[TBL] [Abstract][Full Text] [Related]
18. Antagonism between Staphylococcus epidermidis and Propionibacterium acnes and its genomic basis.
Christensen GJ; Scholz CF; Enghild J; Rohde H; Kilian M; Thürmer A; Brzuszkiewicz E; Lomholt HB; Brüggemann H
BMC Genomics; 2016 Feb; 17():152. PubMed ID: 26924200
[TBL] [Abstract][Full Text] [Related]
19. [Biotyping of Propionibacterium acnes strains isolated from patients with acne vulgaris].
Ergin C; Kaleli I; Sahin R; Ergin S; Kaçar N
Mikrobiyol Bul; 2006; 40(1-2):15-21. PubMed ID: 16775952
[TBL] [Abstract][Full Text] [Related]
20. Resolution of inflammatory acne vulgaris may involve regulation of CD4+ T-cell responses to Propionibacterium acnes.
Wilcox HE; Farrar MD; Cunliffe WJ; Holland KT; Ingham E
Br J Dermatol; 2007 Mar; 156(3):460-5. PubMed ID: 17300234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
